Market News

Latest financial and economic news and analysis

Zacks Investment Research News Agency
2 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

Inogen (INGN) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.15 per share a year ago.

Related Symbols 1
INGN INGN
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Zacks Investment Research News Agency
2 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
Mach Natural Resources LP (MNR) Q2 Earnings and Revenues Beat Estimates

Mach Natural Resources LP (MNR) Q2 Earnings and Revenues Beat Estimates

Mach Natural Resources LP (MNR) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.76 per share a year ago.

Related Symbols 1
MNR MNR
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
2 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
Onto Innovation (ONTO) Q2 Earnings and Revenues Beat Estimates

Onto Innovation (ONTO) Q2 Earnings and Revenues Beat Estimates

Onto Innovation (ONTO) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.25 per share a year ago.

Related Symbols 1
ONTO ONTO
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
2 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
Morgan Stanley Direct Lending Fund (MSDL) Surpasses Q2 Earnings and Revenue Estimates

Morgan Stanley Direct Lending Fund (MSDL) Surpasses Q2 Earnings and Revenue Estimates

Morgan Stanley Direct Lending Fund (MSDL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.5 per share a year ago.

Related Symbols 1
MSDL MSDL
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Zacks Investment Research News Agency
2 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $2.1 per share a year ago.

Related Symbols 1
ICUI ICUI
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Seeking Alpha News Agency
2 days ago•Seeking Alpha
Stocks Medium Importance Neutral
U.S. Physical Therapy Continues To Heal

U.S. Physical Therapy Continues To Heal

U.S. Physical Therapy, Inc. remains rated Hold as operational growth is offset by disappointing profitability and fair valuation. USPH exceeded revenue expectations in Q2 2026, but EPS fell short due to one-time events and rising costs. Clinic expansion, hospital affiliations, and industrial injury prevention services are driving top-line growth and future margin improvement.

Related Symbols 1
USPH USPH
Source: Seeking Alpha
Visit Source
0 0 0
Read More
Comment
GlobeNewsWire News Agency
2 days ago•GlobeNewsWire
Stocks Medium Importance Neutral
Resouro Completes First Tranche of Upsized Private Placement Raising up to $2.5 Million

Resouro Completes First Tranche of Upsized Private Placement Raising up to $2.5 Million

THIS PRESS RELEASE SHALL NOT BE DISTRIBUTED IN THE UNITED STATES OR DISSEMINATED TO U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Resouro Strategic Metals Inc. (ASX: RAU; TSX-V: RSM; FSE: 8TX) ("Resouro" or the "Company") is pleased to announce that it has now completed the first closing of its previously announced non-brokered private placement (the “Offering”). Further to its news release dated July 8, 2026, Canada (July 9, 2026, Australia), The Company is pleased to announce that, due to strong investor demand, it has increased the size of its previously announced non-brokered private placement from 8,000,000 common shares at a price of $0.25 per common share for gross proceeds of $2,000,000 to 10,000,000 common shares at a price of $0.25 per common share for aggregate gross proceeds of $2,500,000.

Related Symbols 1
RSGOF RSGOF
Source: GlobeNewsWire
Visit Source
0 0 0
Read More
Comment